CALL - SPRINTER OPEN END - EDWARDS LIFESCIENCES | Delayed Deutsche Boerse AG 09:14:42 02/07/2024 BST | ||
| 2.77 EUR | -2.12% |
|
| Current month | -8.41% | ||
| 1 month | +15.04% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 02/07/24 | 2.77 | -2.12% |
| 01/07/24 | 2.83 | -8.41% |
| 28/06/24 | 3.09 | -1.28% |
| 27/06/24 | 3.13 | +5.74% |
| 26/06/24 | 2.96 | +3.86% |
Delayed Quote Deutsche Boerse AG
Last update July 02, 2024 at 09:14 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM55JA |
| ISIN | DE000VM55JA1 |
| Date issued | 29/11/2023 |
| Strike | 60.31 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.96 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.4 € |
|---|---|
| Lowest since issue | 0.88 € |
| Spread | 0.07 € |
| Spread % | 2.46% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.25
USD
Average target price
96.05
USD
Spread / Average Target
+6.43%
- Stock Market
- Certificates
- Certificat
